Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Orphan Drugs Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
... numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.) to reach $596,921,719,054 by 2031. Drug Stores ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis period. ... Read More
-
Pharmacy Benefit Management
... at a CAGR of 3.9% over the analysis period 2024-2030. Specialty Pharmacy Services, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$261.1 Billion by the end ... Read More
-
e-Prescription Systems
... CAGR of 16.7% over the analysis period 2024-2030. Solutions, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.2 Billion by the end of the analysis period. ... Read More
-
ePharmacies
... 14.9% over the analysis period 2024-2030. Over-The-Counter (OTC) Drugs, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$127.2 Billion by the end of the analysis period. ... Read More
-
Pharmacy Repackaging Systems
... at a CAGR of 7.3% over the analysis period 2024-2030. Blister Card/Compliance Packaging Systems, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.0 Billion by the ... Read More
-
Compounding Pharmacy
... CAGR of 4.5% over the analysis period 2024-2030. Oral Drugs, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Pharmacy Management Systems
... at a CAGR of 11.5% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$15.5 Billion by the end of ... Read More
-
Health Information Exchange (HIE)
... 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Private Set-Up, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$2.4 Billion by the ... Read More
-
Emergency Department Information Systems
... 2030, growing at a CAGR of 11.9% over the analysis period 2024-2030. Enterprise Solutions, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.1 Billion by the ... Read More
-
Registered Online Pharmacies (UK) - Industry Report
... Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Registered Online Pharmacies (UK) report will tell you the ... Read More
-
Rosacea Treatment Market Report by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others), Route of Administration (Topical, Oral), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... The rising demand for oral treatments and the expanding pharmaceutical industry are primarily driving the market. Rosacea treatment refers to preventive measures adopted to cure a chronic skin disease that enlarges blood vessels and causes ... Read More
-
Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)
... segmentation By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Channel) for the historical period of 2021-2024, ... Read More
-
High Volume Dispensing Systems
... 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Systems / Cabinets, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.6 Billion by ... Read More
-
Pharmacy Inventory Management Software Solutions and Cabinets
... expected to reach US$11.4 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Decentralized Systems, one of the segments analyzed in the report, is expected to record a 10.2% CAGR ... Read More
-
Pharmacy Automation
... CAGR of 6.9% over the analysis period 2024-2030. Medication Dispensing Systems, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Hospital Information Systems Market by Component (Service, Software), product type (EHR, CDSS, Specialty, Diagnostic, Pharmacy, Quality, SCM, PHM, RCM, Data Analytics, Telehealth), Deployment (On-Premises, Cloud-Based), Region - Global Forecast to 2030
... systems market is attributed to government initiatives such as financial incentives from Medicare and Medicaid, exemplified by the NY Medicaid EHR Incentive Program offering up to USD 63,750 over six years, which has significantly accelerated ... Read More
-
Osteoporosis Drugs Global Market Opportunities And Strategies To 2034
... it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being affected by ... Read More
-
Dispensing Chemists in the UK - Industry Market Research Report
... pressure due to regulatory amendments and the loss of patent protection. The government and industry bodies have fought to save dispensing chemists in light of these challenging conditions. Industry assistance initiatives include the Pharmacy Access ... Read More
-
Schizophrenia Drugs Market Size, Share, and Outlook, 2025 Report- By Treatment (Oral, Injectable), By Therapeutic Class (Second-Generation Antipsychotics (Risperdal, Invega, Zyprexa, Geodon, Seroquel, Latuda, Aristada, Fanapt, Saphris, Vraylar), Third-Generation Antipsychotics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Schizophrenia Drugs segments across 22 countries from 2021 to 2032. ... Read More
-
Tumor Necrosis Factor Inhibitor Drugs Market Size, Share, and Outlook, 2025 Report- By Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Others), By Sales Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies), 2021-2032
... is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Tumor ... Read More
-
Pneumonia Therapeutics Market Size, Share, and Outlook, 2025 Report- By Therapeutics (Prevention vaccines, Treatment drugs), By Distribution Channel (Hospitals, Pharmaceutical stores, Others), By Age group (Pediatric, Adult, Geriatric), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Pneumonia Therapeutics segments across 22 countries from 2021 to 2032. ... Read More
-
Respiratory Disease Vaccine Market Size, Share, and Outlook, 2025 Report- By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Age group (Pediatric, Adult), By Infection, COVID-19, Influenza, Respiratory Syncytial Virus, Pneumonia, Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Respiratory Disease Vaccine segments across 22 countries ... Read More
-
Carglumic Acid Market Size, Share, and Outlook, 2025 Report- By Dosage Form(Orally Disintegrating Tablets, Dispersible Tablets, Others), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, E-Commerce Channel), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Carglumic Acid segments across 22 countries from 2021 to 2032. ... Read More
Research Assistance
